【24h】

Tools and techniques - Clinical: Paravalvular leak closure

机译:工具和技术-临床:瓣周漏封闭

获取原文
获取原文并翻译 | 示例
       

摘要

In this chapter of Tools and Techniques Clinical, paravalvular leak closure is discussed using a stepwise approach. The following is a summarised overview of this technique. The complete, unabridged version with images is available online at http://www. pcronline.com/eurointervention/70th_issue/227. Paravalvular leak (PVL) is a common problem for mechanical and bioprosthetic valves, occurring in 5-17% of implanted valves. The associated aortic or mitral regurgitation can be associated with haemolysis or heart failure, leading to increased morbidity and mortality. Surgical treatment is associated with a high mortality risk, especially for redo surgery. Indications for paravalvular leak closure include patients with significant regurgitation accompanied by symptoms of congestive heart failure and/or haemolysis. Important contraindications to PVL closure may include presence of active local or systemic infection, active ischaemia, mechanical instability of the prosthetic valve, intracardiac thrombus, and patients with a life expectancy due to comorbidities that is less than six months. This paper will focus on aortic and mitral PVL, with a look at a few special situations regarding these valves.
机译:在“临床工具和技术”这一章中,使用逐步方法讨论了瓣周漏闭合。以下是此技术的概述。带有图像的完整且未删节的版本可从http:// www在线获得。 pcronline.com/eurointervention/70th_issue/227。对于机械瓣膜和生物瓣膜来说,瓣周漏(PVL)是一个普遍的问题,发生在植入瓣膜的5-17%中。相关的主动脉或二尖瓣关闭不全可能与溶血或心力衰竭相关,从而导致发病率和死亡率增加。手术治疗与高死亡风险相关,尤其是对于重做手术。瓣膜旁渗漏的适应症包括严重反流并伴有充血性心力衰竭和/或溶血症状的患者。 PVL闭合的重要禁忌症可能包括存在活动性局部或全身感染,活动性局部缺血,人工瓣膜机械不稳,心脏内血栓以及由于合并症少于六个月而预期寿命的患者。本文将重点讨论主动脉和二尖瓣PVL,并探讨有关这些瓣膜的一些特殊情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号